Evaluation of RANKL/OPG Serum Concentration Ratio as a New Biomarker for Coronary Artery Calcification: A Pilot Study

Objective. There is a strong need for biomarkers to identify patients at risk for future cardiovascular events related with progressive atherosclerotic disease. Osteoprotegerin (OPG) protects the skeleton from excessive bone resorption by binding to receptor activator of nuclear factor-κB ligand (RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadpour, Amir Hooshang, Shamsara, Jamal, Nazemi, Saeed, Ghadirzadeh, Samira, Shahsavand, Shabnam, Ramezani, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329856/
https://www.ncbi.nlm.nih.gov/pubmed/22577539
http://dx.doi.org/10.1155/2012/306263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329856/
https://www.ncbi.nlm.nih.gov/pubmed/22577539
http://dx.doi.org/10.1155/2012/306263

Ejemplares similares